Final report says UK infected blood scandal “should have been avoided”
Nearly 30,000 people, including children in clinical trials, were infected with hepatitis C and HIV from contaminated blood products in the 1970s and 1980s.
Biopharmaceutical Industry
Companies prepare for ADC trial readouts at ASCO 2024
Biotechs face upward battle with recruiting patients on obesity trials
Novartis plans to axe 680 employees
Incannex prepares IND submission for psychotherapy asset
FDA maps out process for sponsors to charge for drugs in clinical trials
Allakos cuts employee count by half after two Phase II failures
Pharma industry groups push initiatives against climate change at COP28
